Dapagliflozin Counteracts the Proapoptotic Effects of the Secretome of Visceral Adipose Cells from Obese Subjects in Human Cardiac Progenitor Cells via the SGLT2 Cotransporter

Giuseppe Palma; Cristina Caccioppoli; Rossella Doria; Valentina Annamaria Genchi; Isabella Calderoni; Antonio Braun; Giuseppe Santarpino; Aldo D. Milano; Angelo Cignarelli; Annalisa Natalicchio; Luigi Laviola; Angela Pezzolla; Francesco Giorgino; Sebastio Perrini

doi:10.2337/db23-246-OR

Dapagliflozin Counteracts the Proapoptotic Effects of the Secretome of Visceral Adipose Cells from Obese Subjects in Human Cardiac Progenitor Cells via the SGLT2 Cotransporter

Giuseppe Palma
, Cristina Caccioppoli
, Rossella Doria
, Valentina Annamaria Genchi
, Isabella Calderoni
, Antonio Braun
, Giuseppe Santarpino
, Aldo D. Milano
, Angelo Cignarelli
, Annalisa Natalicchio
, Luigi Laviola
, Angela Pezzolla
, Francesco Giorgino
, Sebastio Perrini

Department of Cardiac Surgery

Research output: Contribution to journal › Abstract (Journal) › peer-review

Original language	English
Number of pages	2
Journal	DIABETES
Volume	72
DOIs	https://doi.org/10.2337/db23-246-OR
Publication status	Published - Jun 2023
Event	83rd Annual Scientific Sessions of the American-Diabetes-Association (ADA) - San Diego, Canada Duration: 23 Jun 2023 → 26 Jun 2023

Access to Document

10.2337/db23-246-OR

Cite this

Palma, G., Caccioppoli, C., Doria, R., Genchi, V. A., Calderoni, I., Braun, A., Santarpino, G., Milano, A. D., Cignarelli, A., Natalicchio, A., Laviola, L., Pezzolla, A., Giorgino, F., & Perrini, S. (2023). Dapagliflozin Counteracts the Proapoptotic Effects of the Secretome of Visceral Adipose Cells from Obese Subjects in Human Cardiac Progenitor Cells via the SGLT2 Cotransporter. DIABETES , 72. https://doi.org/10.2337/db23-246-OR

Palma, Giuseppe ; Caccioppoli, Cristina ; Doria, Rossella et al. / Dapagliflozin Counteracts the Proapoptotic Effects of the Secretome of Visceral Adipose Cells from Obese Subjects in Human Cardiac Progenitor Cells via the SGLT2 Cotransporter. In: DIABETES 2023 ; Vol. 72.

@article{b2b89e3704a04040aa415355b994e9b6,

title = "Dapagliflozin Counteracts the Proapoptotic Effects of the Secretome of Visceral Adipose Cells from Obese Subjects in Human Cardiac Progenitor Cells via the SGLT2 Cotransporter",

author = "Giuseppe Palma and Cristina Caccioppoli and Rossella Doria and Genchi, \{Valentina Annamaria\} and Isabella Calderoni and Antonio Braun and Giuseppe Santarpino and Milano, \{Aldo D.\} and Angelo Cignarelli and Annalisa Natalicchio and Luigi Laviola and Angela Pezzolla and Francesco Giorgino and Sebastio Perrini",

year = "2023",

month = jun,

doi = "10.2337/db23-246-OR",

language = "English",

volume = "72",

journal = "DIABETES ",

issn = "0012-1797",

publisher = "Amer Diabetes Assoc",

note = "83rd Annual Scientific Sessions of the American-Diabetes-Association (ADA) ; Conference date: 23-06-2023 Through 26-06-2023",

}

Palma, G, Caccioppoli, C, Doria, R, Genchi, VA, Calderoni, I, Braun, A, Santarpino, G, Milano, AD, Cignarelli, A, Natalicchio, A, Laviola, L, Pezzolla, A, Giorgino, F & Perrini, S 2023, 'Dapagliflozin Counteracts the Proapoptotic Effects of the Secretome of Visceral Adipose Cells from Obese Subjects in Human Cardiac Progenitor Cells via the SGLT2 Cotransporter', DIABETES , vol. 72. https://doi.org/10.2337/db23-246-OR

Dapagliflozin Counteracts the Proapoptotic Effects of the Secretome of Visceral Adipose Cells from Obese Subjects in Human Cardiac Progenitor Cells via the SGLT2 Cotransporter. / Palma, Giuseppe; Caccioppoli, Cristina; Doria, Rossella et al.
In: DIABETES , Vol. 72, 06.2023.

Research output: Contribution to journal › Abstract (Journal) › peer-review

TY - JOUR

T1 - Dapagliflozin Counteracts the Proapoptotic Effects of the Secretome of Visceral Adipose Cells from Obese Subjects in Human Cardiac Progenitor Cells via the SGLT2 Cotransporter

AU - Palma, Giuseppe

AU - Caccioppoli, Cristina

AU - Doria, Rossella

AU - Genchi, Valentina Annamaria

AU - Calderoni, Isabella

AU - Braun, Antonio

AU - Santarpino, Giuseppe

AU - Milano, Aldo D.

AU - Cignarelli, Angelo

AU - Natalicchio, Annalisa

AU - Laviola, Luigi

AU - Pezzolla, Angela

AU - Giorgino, Francesco

AU - Perrini, Sebastio

PY - 2023/6

Y1 - 2023/6

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=pmu_pure&SrcAuth=WosAPI&KeyUT=WOS:001052854601052&DestLinkType=FullRecord&DestApp=WOS

U2 - 10.2337/db23-246-OR

DO - 10.2337/db23-246-OR

M3 - Abstract (Journal)

SN - 0012-1797

VL - 72

JO - DIABETES

JF - DIABETES

T2 - 83rd Annual Scientific Sessions of the American-Diabetes-Association (ADA)

Y2 - 23 June 2023 through 26 June 2023

ER -

Palma G, Caccioppoli C, Doria R, Genchi VA, Calderoni I, Braun A et al. Dapagliflozin Counteracts the Proapoptotic Effects of the Secretome of Visceral Adipose Cells from Obese Subjects in Human Cardiac Progenitor Cells via the SGLT2 Cotransporter. DIABETES . 2023 Jun;72. doi: 10.2337/db23-246-OR

Dapagliflozin Counteracts the Proapoptotic Effects of the Secretome of Visceral Adipose Cells from Obese Subjects in Human Cardiac Progenitor Cells via the SGLT2 Cotransporter

Access to Document

Other files and links

Cite this